Diametric Capital, LP - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 36 filers reported holding OCUPHIRE PHARMA INC in Q4 2022. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
Diametric Capital, LP ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2023$187,797
+53.4%
56,059
+98.7%
0.08%
+43.6%
Q2 2023$122,444
-41.3%
28,213
-49.3%
0.06%
-45.0%
Q1 2023$208,680
+150.5%
55,648
+135.8%
0.10%
+150.0%
Q4 2022$83,301
+70.0%
23,598
-3.9%
0.04%
+60.0%
Q3 2022$49,000
-25.8%
24,548
-28.5%
0.02%
-49.0%
Q2 2022$66,000
-60.2%
34,356
-33.3%
0.05%
-46.7%
Q1 2022$166,000
-50.3%
51,531
-42.4%
0.09%
-64.1%
Q4 2021$334,00089,4420.26%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 368,003$1,232,8122.32%
Knoll Capital Management, LLC 100,000$335,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 828,628$2,775,9040.18%
Diametric Capital, LP 56,059$187,7970.08%
THOMPSON DAVIS & CO., INC. 17,000$56,9500.07%
MAI Capital Management 455,677$1,526,5180.02%
TRUST CO OF TOLEDO NA /OH/ 30,963$103,7260.02%
BEDEL FINANCIAL CONSULTING INC 15,000$50,2500.01%
Legato Capital Management LLC 10,098$33,8280.01%
Stokes Family Office, LLC 13,030$43,6510.01%
View complete list of OCUPHIRE PHARMA INC shareholders